- Inogen Inc. (INGN, Financial) will announce its Q1 2025 financial results on May 7, 2025, post-market close.
- A conference call discussing the results is scheduled for 2:00 p.m. PT / 5:00 p.m. ET on the same day.
- The earnings call will be accessible via phone or webcast, with replay options available until May 14, 2025.
Inogen Inc. (INGN), a prominent player in the medical technology sector, has confirmed that it will release its financial results for the first quarter of 2025 on May 7, 2025, after the stock market closes. This announcement comes as part of the company's efforts to keep investors informed about its financial health and business performance.
The company has scheduled a conference call for the same day at 2:00 p.m. Pacific Time (PT) / 5:00 p.m. Eastern Time (ET), where Inogen's management will discuss the results in detail. Participants can join the call by dialing (877) 841-3961 for U.S. callers and (201) 689-8589 for international callers. The conference call will also be broadcasted live via an audio webcast accessible through the News / Events page on Inogen's Investor Relations website.
For those unable to attend the live session, a replay of the conference call will be available until May 14, 2025. Interested parties can access the replay by calling (877) 660-6853 or (201) 612-7415, using Conference ID: 13752582.
Inogen Inc. specializes in innovative respiratory products tailored for homecare, offering solutions that enhance the quality of life for patients with chronic respiratory conditions. The company's Q1 2025 earnings report is keenly anticipated by stakeholders eager to assess its financial trajectory and operational strategies.
